{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:58:48Z","timestamp":1792022328035,"version":"4.4.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T00:00:00Z","timestamp":1522972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020","doi-asserted-by":"publisher","award":["CA15111"],"award-info":[{"award-number":["CA15111"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.autrev.2018.01.009","type":"journal-article","created":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T05:10:39Z","timestamp":1523077839000},"page":"601-609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":261,"title":["Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome \u2013 Evidence for an autoimmune disease"],"prefix":"10.1016","volume":"17","author":[{"given":"Franziska","family":"Sotzny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00e0","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Capelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Castro-Marrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modra","family":"Murovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Scheibenbogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2018.01.009_bb0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2796.2011.02428.x","article-title":"Myalgic encephalomyelitis: international consensus criteria","volume":"270","author":"Carruthers","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2018.01.009_bb0010","first-page":"365","article-title":"EBV and autoimmunity","volume":"390","author":"Ascherio","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2018.01.009_bb0015","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.humimm.2015.09.028","article-title":"Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome","volume":"76","author":"Guenther","year":"2015","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0020","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1097\/00007611-198411000-00007","article-title":"Chronic mononucleosis syndrome","volume":"77","author":"DuBois","year":"1984","journal-title":"South Med J"},{"key":"10.1016\/j.autrev.2018.01.009_bb0025","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1086\/513627","article-title":"Chronic parvovirus B19 infection resulting in chronic fatigue syndrome: case history and review","volume":"24","author":"Jacobson","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2018.01.009_bb0030","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1749-6632.2009.04799.x","article-title":"Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence?","volume":"1173","author":"Ortega-Hernandez","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2018.01.009_bb0035","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/clinids\/19.3.448","article-title":"Simultaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: is there evidence of activation of a nonspecific polyclonal immune response?","volume":"19","author":"Manian","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2018.01.009_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085387","article-title":"Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome","volume":"9","author":"Loebel","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.01.009_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179124","article-title":"Serological profiling of the EBV immune response in chronic fatigue syndrome using a peptide microarray","volume":"12","author":"Loebel","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.01.009_bb0050","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/978-1-4419-8216-2_7","article-title":"Epigenetic dysregulation of epstein-barr virus latency and development of autoimmune disease","volume":"711","author":"Niller","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0055","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1096\/fj.11-190769","article-title":"Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross-react with myelin basic protein and EBV antigen","volume":"25","author":"Gabibov","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.autrev.2018.01.009_bb0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1386-6532(99)00079-7","article-title":"Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients","volume":"16","author":"Ablashi","year":"2000","journal-title":"J Clin Virol"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2018.01.009_bb0065","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/S1386-6532(06)70011-7","article-title":"Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome","volume":"37","author":"Chapenko","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0070","first-page":"209","article-title":"Detection of herpesviruses and parvovirus B19 in gastric and intestinal mucosa of chronic fatigue syndrome patients","volume":"23","author":"Fremont","year":"2009","journal-title":"In Vivo"},{"key":"10.1016\/j.autrev.2018.01.009_bb0075","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1128\/JCM.33.6.1660-1661.1995","article-title":"Human herpesvirus 6 and human herpesvirus 7 in chronic fatigue syndrome","volume":"33","author":"Di Luca","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0080","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/205085","article-title":"Association of active human herpesvirus-6, -7 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"2012","author":"Chapenko","year":"2012","journal-title":"Adv Virol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0085","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/cid\/cit086","article-title":"Human endogenous retrovirus-K18 superantigen expression and human herpesvirus-6 and human herpesvirus-7 viral loads in chronic fatigue patients","volume":"56","author":"Oakes","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2018.01.009_bb0090","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jmv.20511","article-title":"Latent infection of human herpesvirus 7 in CD4(+) T lymphocytes","volume":"78","author":"Miyake","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0095","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/jmv.20240","article-title":"Quantitative analysis of human herpesvirus 6 cell tropism","volume":"75","author":"De Bolle","year":"2005","journal-title":"J Med Virol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/867389","article-title":"Possible role of human herpesvirus 6 as a trigger of autoimmune disease","volume":"2013","author":"Broccolo","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.autrev.2018.01.009_bb0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.10425","article-title":"Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis","volume":"53","author":"Tejada-Simon","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0110","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/jmv.24810","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses-encoded dUTPase: implications in disease pathophysiology","volume":"89","author":"Halpin","year":"2017","journal-title":"J Med Virol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0115","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/jclinpath-2015-203455","article-title":"The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease","volume":"69","author":"Kerr","year":"2016","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0120","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1099\/0022-1317-82-12-3011","article-title":"Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue","volume":"82","author":"Kerr","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0125","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1086\/374666","article-title":"Successful intravenous immunoglobulin therapy in 3 cases of parvovirus B19-associated chronic fatigue syndrome","volume":"36","author":"Kerr","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2018.01.009_bb0130","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.inf.0000155194.66797.20","article-title":"Persistent parvovirus-associated chronic fatigue treated with high dose intravenous immunoglobulin","volume":"24","author":"McGhee","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.autrev.2018.01.009_bb0135","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/cei.12795","article-title":"CD21(-\/low) B cells in human blood are memory cells","volume":"185","author":"Thorarinsdottir","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0140","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1182\/blood-2009-09-243071","article-title":"Complement receptor 2\/CD21- human naive B cells contain mostly autoreactive unresponsive clones","volume":"115","author":"Isnardi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2018.01.009_bb0145","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/art.37828","article-title":"Expansion of autoreactive unresponsive CD21-\/low B cells in Sjogren's syndrome-associated lymphoproliferation","volume":"65","author":"Saadoun","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.01.009_bb0150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.clim.2004.05.010","article-title":"A new CD21low B cell population in the peripheral blood of patients with SLE","volume":"113","author":"Wehr","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0155","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1128\/JCM.28.6.1403-1410.1990","article-title":"Immunologic abnormalities in chronic fatigue syndrome","volume":"28","author":"Klimas","year":"1990","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0160","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-3083.1994.tb03511.x","article-title":"Immunological abnormalities in patients with chronic fatigue syndrome","volume":"40","author":"Tirelli","year":"1994","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/cei.12043","article-title":"Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls","volume":"172","author":"Bradley","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0170","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/intimm\/dxt068","article-title":"Role of adaptive and innate immune cells in chronic fatigue syndrome\/myalgic encephalomyelitis","volume":"26","author":"Brenu","year":"2014","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0175","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/cei.12749","article-title":"Extended B cell phenotype in patients with myalgic encephalomyelitis\/chronic fatigue syndrome: a cross-sectional study","volume":"184","author":"Mensah","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0180","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12967-015-0628-4","article-title":"Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome","volume":"13","author":"Lobel","year":"2015","journal-title":"J Transl Med"},{"key":"10.1016\/j.autrev.2018.01.009_bb0185","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12967-017-1201-0","article-title":"Whole blood gene expression in adolescent chronic fatigue syndrome: an exploratory cross-sectional study suggesting altered B cell differentiation and survival","volume":"15","author":"Nguyen","year":"2017","journal-title":"J Transl Med"},{"key":"10.1016\/j.autrev.2018.01.009_bb0190","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nri3095","article-title":"TLR-dependent T cell activation in autoimmunity","volume":"11","author":"Mills","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0195","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0140-6736(91)91440-6","article-title":"Chronic fatigue syndrome: clinical condition associated with immune activation","volume":"338","author":"Landay","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2018.01.009_bb0200","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1479-5876-11-68","article-title":"Screening NK-, B- and T-cell phenotype and function in patients suffering from chronic fatigue syndrome","volume":"11","author":"Curriu","year":"2013","journal-title":"J Transl Med"},{"key":"10.1016\/j.autrev.2018.01.009_bb0205","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/infdis\/173.2.460","article-title":"Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome","volume":"173","author":"Swanink","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2018.01.009_bb0210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1479-5876-9-81","article-title":"Immunological abnormalities as potential biomarkers in chronic fatigue syndrome\/Myalgic encephalomyelitis","volume":"9","author":"Brenu","year":"2011","journal-title":"J Transl Med"},{"key":"10.1016\/j.autrev.2018.01.009_bb0215","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12865-015-0101-4","article-title":"Characterisation of cell functions and receptors in chronic fatigue syndrome\/Myalgic encephalomyelitis (CFS\/ME)","volume":"16","author":"Hardcastle","year":"2015","journal-title":"BMC Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0220","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9064529","article-title":"A preliminary comparative assessment of the role of CD8+ T cells in chronic fatigue syndrome\/myalgic encephalomyelitis and multiple sclerosis","volume":"2016","author":"Brenu","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.autrev.2018.01.009_bb0225","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3389\/fimmu.2017.00723","article-title":"Unperturbed cytotoxic lymphocyte phenotype and function in myalgic encephalomyelitis\/chronic fatigue syndrome patients","volume":"8","author":"Theorell","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0230","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nri3447","article-title":"The good, the bad and the ugly - TFH cells in human health and disease","volume":"13","author":"Tangye","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0235","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","article-title":"The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease","volume":"148","author":"Afzali","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0240","first-page":"300","article-title":"Regulatory T, natural killer T and gammadelta T cells in multiple sclerosis and chronic fatigue syndrome\/myalgic encephalomyelitis: a comparison","volume":"34","author":"Ramos","year":"2016","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0245","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1479-5876-10-88","article-title":"Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome\/myalgic encephalomyelitis","volume":"10","author":"Brenu","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.autrev.2018.01.009_bb0250","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2018.01.009_bb0255","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1172\/JCI118990","article-title":"Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome","volume":"98","author":"Konstantinov","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2018.01.009_bb0260","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/rheumatology\/40.7.806","article-title":"Autoantibodies to a 68\/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia: a possible marker for hypersomnia and cognitive disorders","volume":"40","author":"Nishikai","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2018.01.009_bb0265","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbi.2015.09.013","article-title":"Antibodies to beta adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome","volume":"52","author":"Loebel","year":"2016","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.autrev.2018.01.009_bb0270","first-page":"225","article-title":"Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome","volume":"12","author":"Tanaka","year":"2003","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.autrev.2018.01.009_bb0275","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/art.1780400215","article-title":"High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome","volume":"40","author":"von Mikecz","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.01.009_bb0280","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1749-6632.2009.04802.x","article-title":"Autoantibodies, polymorphisms in the serotonin pathway, and human leukocyte antigen class II alleles in chronic fatigue syndrome: are they associated with age at onset and specific symptoms?","volume":"1173","author":"Ortega-Hernandez","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2018.01.009_bb0285","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.autrev.2012.02.013","article-title":"Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis","volume":"12","author":"Op De Beeck","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.01.009_bb0290","first-page":"21","article-title":"High incidence of antibodies to 5-hydroxytryptamine, gangliosides and phospholipids in patients with chronic fatigue and fibromyalgia syndrome and their relatives: evidence for a clinical entity of both disorders","volume":"1","author":"Klein","year":"1995","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.autrev.2018.01.009_bb0295","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jcla.20217","article-title":"Acute phase phospholipids related to the cardiolipin of mitochondria in the sera of patients with chronic fatigue syndrome (CFS), chronic Ciguatera fish poisoning (CCFP), and other diseases attributed to chemicals, Gulf War, and marine toxins","volume":"22","author":"Hokama","year":"2008","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.autrev.2018.01.009_bb0300","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/jcla.20325","article-title":"Anticardiolipin antibodies in the sera of patients with diagnosed chronic fatigue syndrome","volume":"23","author":"Hokama","year":"2009","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.autrev.2018.01.009_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051515","article-title":"Reduction of [11C](+)3-MPB binding in brain of chronic fatigue syndrome with serum autoantibody against muscarinic cholinergic receptor","volume":"7","author":"Yamamoto","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.01.009_bb0310","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/joim.12161","article-title":"Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort","volume":"275","author":"Reynolds","year":"2014","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2018.01.009_bb0315","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/qjmed\/hcn123","article-title":"Postural orthostatic tachycardia syndrome is an under- recognized condition in chronic fatigue syndrome","volume":"101","author":"Hoad","year":"2008","journal-title":"QJM"},{"key":"10.1016\/j.autrev.2018.01.009_bb0320","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.amjmed.2005.06.013","article-title":"Orthostatic instability in a population-based study of chronic fatigue syndrome","volume":"118","author":"Jones","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2018.01.009_bb0325","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/0961203316629558","article-title":"Postural orthostatic tachycardia syndrome (POTS)\u2014a novel member of the autoimmune family","volume":"25","author":"Dahan","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2018.01.009_bb0330","first-page":"615","article-title":"Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins","volume":"27","author":"Maes","year":"2006","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.autrev.2018.01.009_bb0335","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11011-012-9316-8","article-title":"IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS) than in major depression","volume":"27","author":"Maes","year":"2012","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.autrev.2018.01.009_bb0340","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/jir.2011.0065","article-title":"Cytokines in autoimmunity: role in induction, regulation, and treatment","volume":"31","author":"Moudgil","year":"2011","journal-title":"J Interf Cytokine Res"},{"key":"10.1016\/j.autrev.2018.01.009_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2014.11.019","article-title":"Cytokine expression provides clues to the pathophysiology of Gulf War illness and myalgic encephalomyelitis","volume":"72","author":"Khaiboullina","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2018.01.009_bb0350","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2249.2004.02354.x","article-title":"High levels of type 2 cytokine- producing cells in chronic fatigue syndrome","volume":"135","author":"Skowera","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0355","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1479-5876-7-96","article-title":"Plasma cytokines in women with chronic fatigue syndrome","volume":"7","author":"Fletcher","year":"2009","journal-title":"J Transl Med"},{"key":"10.1016\/j.autrev.2018.01.009_bb0360","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2016.12.008","article-title":"Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME) symptoms in women","volume":"303","author":"Milrad","year":"2017","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0365","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1710519114","article-title":"Cytokine signature associated with disease severity in chronic fatigue syndrome patients","volume":"114","author":"Montoya","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2018.01.009_bb0370","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1400121","article-title":"Distinct plasma immune signatures in ME\/CFS are present early in the course of illness","volume":"1","author":"Hornig","year":"2015","journal-title":"Sci Adv"},{"key":"10.1016\/j.autrev.2018.01.009_bb0375","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbi.2015.07.004","article-title":"Chronic fatigue syndrome and circulating cytokines: a systematic review","volume":"50","author":"Blundell","year":"2015","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.autrev.2018.01.009_bb0380","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/cei.13023","article-title":"Cytokine responses to exercise and activity in patients with chronic fatigue syndrome: case-control study","volume":"190","author":"Clark","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0385","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2249.2009.04007.x","article-title":"BAFF: a local and systemic target in autoimmune diseases","volume":"158","author":"Moisini","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0390","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/leu.2015.174","article-title":"The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells","volume":"30","author":"Saulep-Easton","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.autrev.2018.01.009_bb0395","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nri2572","article-title":"Cracking the BAFF code","volume":"9","author":"Mackay","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161226","article-title":"Serum BAFF and APRIL levels, T-lymphocyte subsets, and Immunoglobulins after B-cell depletion using the monoclonal anti-CD20 antibody rituximab in Myalgic Encephalopathy\/Chronic Fatigue Syndrome","volume":"11","author":"Lunde","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.01.009_bb0405","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1196\/annals.1313.004","article-title":"BAFF overexpression is associated with autoantibody production in autoimmune diseases","volume":"1050","author":"Pers","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2018.01.009_bb0410","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cytogfr.2013.03.003","article-title":"The activins and their binding protein, follistatin-diagnostic and therapeutic targets in inflammatory disease and fibrosis","volume":"24","author":"Hedger","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.autrev.2018.01.009_bb0415","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12967-017-1161-4","article-title":"Activin B is a novel biomarker for chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME) diagnosis: a cross sectional study","volume":"15","author":"Lidbury","year":"2017","journal-title":"J Transl Med"},{"key":"10.1016\/j.autrev.2018.01.009_bb0420","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/s10165-003-0224-y","article-title":"CD26: a key molecule in immune regulation and autoimmune diseases","volume":"13","author":"Hosono","year":"2003","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010817","article-title":"Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV\/CD26","volume":"5","author":"Fletcher","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.01.009_bb0430","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12967-016-1010-x","article-title":"Association of biomarkers with health-related quality of life and history of stressors in myalgic encephalomyelitis\/chronic fatigue syndrome patients","volume":"14","author":"Fenouillet","year":"2016","journal-title":"J Transl Med"},{"key":"10.1016\/j.autrev.2018.01.009_bb0435","first-page":"1757","article-title":"Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis","volume":"82","author":"Okumura","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2018.01.009_bb0440","first-page":"759","article-title":"Circulating soluble CD30 levels in primary Sjogren's syndrome, SLE and rheumatoid arthritis","volume":"16","author":"Ichikawa","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0445","first-page":"41","article-title":"CD30 expression on CD1a+ and CD8+ cells in atopic dermatitis and correlation with disease severity","volume":"18","author":"Oflazoglu","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0450","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/immu.1994.1008","article-title":"Soluble Fc\u03f5RII\/CD23 in patients with autoimmune diseases and Epstein-Barr virus-related disorders: analysis by ELISA for soluble Fc\u03f5RII\/CD23","volume":"4","author":"Yoshikawa","year":"1994","journal-title":"ImmunoMethods"},{"key":"10.1016\/j.autrev.2018.01.009_bb0455","first-page":"336","article-title":"The soluble CTLA-4 receptor: a new marker in autoimmune diseases","volume":"53","author":"Pawlak","year":"2005","journal-title":"Arch Immunol Ther Exp"},{"key":"10.1016\/j.autrev.2018.01.009_bb0460","first-page":"183","article-title":"Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy","volume":"60","author":"Dejica","year":"2001","journal-title":"Roum Arch Microbiol Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0465","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/jcp.2004.022681","article-title":"Association of chronic fatigue syndrome with human leucocyte antigen class II alleles","volume":"58","author":"Smith","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0470","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1177\/039463200902200320","article-title":"Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome","volume":"22","author":"Carlo-Stella","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0475","first-page":"535","article-title":"Excess of activating killer cell immunoglobulinlike receptors and lack of HLA-Bw4 ligands: a twoedged weapon in chronic fatigue syndrome","volume":"4","author":"Pasi","year":"2011","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.autrev.2018.01.009_bb0480","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/intimm\/dxw002","article-title":"Genetics of autoimmune diseases: perspectives from genome-wide association studies","volume":"28","author":"Kochi","year":"2016","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0485","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jsbmb.2012.08.012","article-title":"Investigation of the vitamin D receptor gene (VDR) and its interaction with protein tyrosine phosphatase, non-receptor type 2 gene (PTPN2) on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY)","volume":"133","author":"Frederiksen","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0490","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1093\/hmg\/ddn184","article-title":"A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5","volume":"17","author":"Sigurdsson","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2018.01.009_bb0495","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants","volume":"360","author":"Hirschfield","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2018.01.009_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154394","article-title":"Association of Cytotoxic T- lymphocyte-associated protein 4 (CTLA4) gene polymorphisms with autoimmune thyroid disease in children and adults: case-control study","volume":"11","author":"Ting","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.01.009_bb0505","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.autrev.2015.05.004","article-title":"Emerging role of long noncoding RNAs in autoimmune diseases","volume":"14","author":"Wu","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.01.009_bb0510","first-page":"179","article-title":"A first study of cytokine genomic polymorphisms in CFS: positive association of TNF-857 and IFNgamma 874 rare alleles","volume":"24","author":"Carlo-Stella","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0515","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.humimm.2015.06.014","article-title":"Pathway-focused genetic evaluation of immune and inflammation related genes with chronic fatigue syndrome","volume":"76","author":"Rajeevan","year":"2015","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0520","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ygeno.2009.06.002","article-title":"An integrated approach to infer causal associations among gene expression, genotype variation, and disease","volume":"94","author":"Lee","year":"2009","journal-title":"Genomics"},{"key":"10.1016\/j.autrev.2018.01.009_bb0525","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1601-183X.2006.00244.x","article-title":"Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome","volume":"6","author":"Rajeevan","year":"2007","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.autrev.2018.01.009_bb0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.it.2011.09.002","article-title":"Intracellular metabolic pathways control immune tolerance","volume":"33","author":"Procaccini","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0535","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/ar3885","article-title":"Energy metabolism and rheumatic diseases: from cell to organism","volume":"14","author":"Spies","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2018.01.009_bb0540","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/icb.2016.77","article-title":"Immunometabolism and autoimmunity","volume":"94","author":"Freitag","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0545","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1756-185X.2011.01598.x","article-title":"Glycolysis and rheumatoid arthritis","volume":"14","author":"Chang","year":"2011","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2018.01.009_bb0550","first-page":"208","article-title":"Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS)","volume":"5","author":"Booth","year":"2012","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.autrev.2018.01.009_bb0555","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000336803","article-title":"Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis\/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis\/chronic fatigue syndrome than in depression","volume":"81","author":"Maes","year":"2012","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.autrev.2018.01.009_bb0560","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1089\/ars.2013.5346","article-title":"Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia?","volume":"19","author":"Castro-Marrero","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.autrev.2018.01.009_bb0565","first-page":"1","article-title":"Targeting mitochondrial dysfunction in the treatment of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS) - a clinical audit","volume":"6","author":"Myhill","year":"2013","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.autrev.2018.01.009_bb0570","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.cca.2012.06.022","article-title":"NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome","volume":"413","author":"Armstrong","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2018.01.009_bb0575","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s11306-015-0816-5","article-title":"Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients","volume":"11","author":"Armstrong","year":"2015","journal-title":"Metabolomics"},{"key":"10.1016\/j.autrev.2018.01.009_bb0580","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89376","article-title":"Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy\/chronic fatigue syndrome","volume":"1","author":"Fluge","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2018.01.009_bb0585","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1039\/C6MB00600K","article-title":"Metabolic profiling of a myalgic encephalomyelitis\/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism","volume":"13","author":"Germain","year":"2017","journal-title":"Mol BioSyst"},{"key":"10.1016\/j.autrev.2018.01.009_bb0590","doi-asserted-by":"crossref","first-page":"E5472","DOI":"10.1073\/pnas.1607571113","article-title":"Metabolic features of chronic fatigue syndrome","volume":"113","author":"Naviaux","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2018.01.009_bb0595","doi-asserted-by":"crossref","DOI":"10.1038\/srep34990","article-title":"Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles","volume":"6","author":"Yamano","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2018.01.009_bb0600","first-page":"24","article-title":"Comorbid clinical conditions in chronic fatigue: a co-twin control study","volume":"16","author":"Aaron","year":"2001","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.autrev.2018.01.009_bb0605","first-page":"77","article-title":"Fibromyalgia and autoimmune diseases: the pain behind autoimmunity","volume":"10","author":"Buskila","year":"2008","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.autrev.2018.01.009_bb0610","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780380104","article-title":"The prevalence and characteristics of fibromyalgia in the general population","volume":"38","author":"Wolfe","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.01.009_bb0615","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.psym.2017.04.010","article-title":"Comorbidity in Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis: a nationwide population-based cohort study","volume":"58","author":"Castro-Marrero","year":"2017","journal-title":"Psychosomatics"},{"key":"10.1016\/j.autrev.2018.01.009_bb0620","first-page":"19","article-title":"Examining those meeting IOM criteria versus IOM plus fibromyalgia","volume":"5","author":"Jason","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2018.01.009_bb0625","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1977.tb01340.x","article-title":"The spectrum of thyroid disease in a community: the Whickham survey","volume":"7","author":"Tunbridge","year":"1977","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0630","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000755","article-title":"Autoimmune basis for postural tachycardia syndrome","volume":"3","author":"Li","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.autrev.2018.01.009_bb0635","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00246-014-0981-8","article-title":"The value of acetylcholine receptor antibody in children with postural tachycardia syndrome","volume":"36","author":"Li","year":"2015","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.autrev.2018.01.009_bb0640","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jash.2011.10.003","article-title":"Autoantibody activation of beta- adrenergic and muscarinic receptors contributes to an \"autoimmune\" orthostatic hypotension","volume":"6","author":"Yu","year":"2012","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.autrev.2018.01.009_bb0645","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129898","article-title":"B-lymphocyte depletion in Myalgic encephalopathy\/ chronic fatigue syndrome. An open-label phase II study with rituximab maintenance treatment","volume":"10","author":"Fluge","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.01.009_bb0650","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0022-3999(99)00013-6","article-title":"Chronic fatigue syndrome in private practice psychiatry: family history of physical and mental health","volume":"47","author":"Endicott","year":"1999","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.autrev.2018.01.009_bb0655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026358","article-title":"Benefit from B- lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double- blind and placebo-controlled study","volume":"6","author":"Fluge","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.01.009_bb0660","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.286.11.1360","article-title":"Interventions for the treatment and management of chronic fatigue syndrome: a systematic review","volume":"286","author":"Whiting","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2018.01.009_bb0665","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/0002-9343(90)90172-A","article-title":"A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome","volume":"89","author":"Peterson","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2018.01.009_bb0670","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0002-9343(90)90173-B","article-title":"A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome","volume":"89","author":"Lloyd","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2018.01.009_bb0675","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9343(97)90045-0","article-title":"Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome","volume":"103","author":"Vollmer-Conna","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2018.01.009_bb0680","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-3956(96)00047-7","article-title":"Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescents","volume":"31","author":"Rowe","year":"1997","journal-title":"J Psychiatr Res"},{"issue":"3","key":"10.1016\/j.autrev.2018.01.009_bb0685","doi-asserted-by":"crossref","first-page":"e0193672","DOI":"10.1371\/journal.pone.0193672","article-title":"Immunoadsorption to remove \u00df2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS\/ME","volume":"13","author":"Scheibenbogen","year":"2018","journal-title":"PLoS One"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218300880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218300880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T04:08:54Z","timestamp":1604117334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997218300880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":137,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1568997218300880"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2018.01.009","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome \u2013 Evidence for an autoimmune disease","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2018.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}